Scherpereel, A., Mansfield, A. S., Grossi, F., Popat, S., Baas, P., Nowak, A. K., Tsao, A. S., Fujimoto, N., Peters, S., Aragon, Y. B., Talbot, T., Kowalski, D., Kaplan, M. A., Cardona, A. F., Soomro, R., Hu, N., Lee, A., Ip, V., Hung, Y., Zalcman, G. (2026). Reply to: “Beyond Response Rates: Interpreting Long-Term Benefit in CheckMate 743” and “Beyond Statistical Significance: Methodological Fragility and Censoring Bias in the 5-Year Update of CheckMate 743”. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-01153